Mira is bringing its version of Oxford Cancer Biomarkers' PGx test to the US in the newly launched ToxNav Advantage assay.

Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...

Biomarker testing is an integral part of personalized genome medicine medicine. Number of actionable biomarkers for solid tumours is rapidly expanding. Targeted NGS is a new gold standard, replacing ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The complexity of software architecture and diverse user interactions presents challenges to ...

SEngine Precision Medicine, the precision oncology innovator matching patients to medicines based on their own tumor samples, announces the publication of a new case report showing a patient’s ...

Acquired CARD11 Mutation Promotes BCR Independence in Diffuse Large B Cell Lymphoma Despite the well-understood benefits of biomarker and genetic testing in precision medicine, uptake remains low, ...

Brussels Airport has dispatched initial test shipments of human cell and blood material to Dallas, advancing standardisation ...